Luks A M, Swenson E R
Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA 98108, USA.
Eur Respir J. 2007 Apr;29(4):770-92. doi: 10.1183/09031936.00052606.
The pathophysiology of high-altitude illnesses has been well studied in normal individuals, but little is known about the risks of high-altitude travel in patients with pre-existing lung disease. Although it would seem self-evident that any patient with lung disease might not do well at high altitude, the type and severity of disease will determine the likelihood of difficulty in a high-altitude environment. The present review examines whether these individuals are at risk of developing one of the main forms of acute or chronic high-altitude illness and whether the underlying lung disease itself will get worse at high elevations. Several groups of pulmonary disorders are considered, including obstructive, restrictive, vascular, control of ventilation, pleural and neuromuscular diseases. Attempts will be made to classify the risks faced by each of these groups at high altitude and to provide recommendations regarding evaluation prior to high-altitude travel, advice for or against taking such excursions, and effective prophylactic measures.
高海拔疾病的病理生理学在正常个体中已得到充分研究,但对于已有肺部疾病的患者进行高海拔旅行的风险却知之甚少。虽然任何肺部疾病患者在高海拔地区可能表现不佳似乎是不言而喻的,但疾病的类型和严重程度将决定在高海拔环境中出现困难的可能性。本综述探讨了这些个体是否有患急性或慢性高海拔疾病主要形式之一的风险,以及潜在的肺部疾病本身在高海拔地区是否会恶化。考虑了几组肺部疾病,包括阻塞性、限制性、血管性、通气控制、胸膜和神经肌肉疾病。将尝试对这些组在高海拔地区面临的风险进行分类,并提供有关高海拔旅行前评估的建议、支持或反对进行此类旅行的建议以及有效的预防措施。